Combination of sibutramine and topiramate for the treatment of obesity: the SIBAMATE retrospective cohort study
In a real-world setting, sibutramine and topiramate combination therapy was associated with clinically meaningful weight loss alongside a good tolerability profile.
Authors
- Matheo Augusto Morandi Stumpf (ORCID: https://orcid.org/0000-0002-6465-0972)
- Márcio C. Mancini (ORCID: https://orcid.org/0000-0003-1278-0406)
- Cíntia Cercato (ORCID: https://orcid.org/0000-0002-6181-4951)
- Maria Edna de Melo (ORCID: https://orcid.org/0000-0002-1216-7532)
- Gabriel Neimann da Cunha Freire
- Eduardo Z Kawahara (ORCID: https://orcid.org/0009-0002-8054-2098)
- Ariana Ester Fernandes
Institutions
- Universidade de São Paulo (BR)
- Santa Casa Hospital (BR)
- Hospital Municipal Souza Aguiar (BR)
Publication Details
- Journal
- Diabetology & Metabolic Syndrome
- Published
- 2025-07-21
- DOI
- https://doi.org/10.1186/s13098-025-01842-1
- Citations
- 1
- Primary Topic
- Pharmacology and Obesity Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.39